Compare · OTIS vs PBAX
OTIS vs PBAX
Side-by-side comparison of Otis Worldwide Corporation (OTIS) and Phoenix Biotech Acquisition Corp. (PBAX): market cap, price performance, sector, and recent activity on the wire.
Summary
- OTIS operates in Technology, while PBAX operates in Industrials - the two are in different parts of the market.
- OTIS is the larger of the two at $26.99B, about 118.5x PBAX ($227.7M).
- OTIS has hit the wire 13 times in the past 4 weeks while PBAX has been quiet.
- OTIS has more recent analyst coverage (25 ratings vs 0 for PBAX).
- Company
- Otis Worldwide Corporation
- Phoenix Biotech Acquisition Corp.
- Price
- $69.64-1.00%
- $5.45+14.26%
- Market cap
- $26.99B
- $227.7M
- 1M return
- -10.14%
- -
- 1Y return
- -26.94%
- -
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- 2021
- News (4w)
- 13
- 0
- Recent ratings
- 25
- 0
Otis Worldwide Corporation
Otis Worldwide Corporation manufactures, installs, and services elevators and escalators in the United States, China, and internationally. The company operates through two segments, New Equipment and Service. The New Equipment segment designs, manufactures, sells, and installs a range of passenger and freight elevators, as well as escalators and moving walkways for residential and commercial buildings, and infrastructure projects. The Service segment performs maintenance and repair services, as well as modernization services to upgrade elevators and escalators. The company was founded in 1853 and is headquartered in Farmington, Connecticut.
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
Latest OTIS
- President, Otis Americas Armas Joseph Jay converted options into 1,680 shares and covered exercise/tax liability with 421 shares, increasing direct ownership by 73% to 2,990 units (SEC Form 4)
- SEC Form 4 filed by Director Kearney Christopher J
- SEC Form 4 filed by Director Bartlett Thomas A
- SEC Form 4 filed by Director Stewart Shelley Jr
- SEC Form 4 filed by Director Walker John H
- SEC Form 4 filed by Director Preston Margaret M V
- Otis Worldwide Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Hannan Kathy Hopinkah
- SEC Form 4 filed by Director Connors Nelda J
- SEC Form 4 filed by Director Brannon Jill
Latest PBAX
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)
- New insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)
- SEC Form D filed by Phoenix Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- SEC Form 4 filed by Laporte Kathleen (Amendment)
- Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)
- SEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- Loewy Caroline M acquired 5,828 shares (SEC Form 4)
- Kosacz Barbara acquired 5,828 shares (SEC Form 4)